Surgical treatment of pressure ulcers: 20-year experience

OI Schryvers, MF Stranc, PW Nance - Archives of physical medicine and …, 2000 - Elsevier
Schryvers OI, Stranc MF, Nance PW. Surgical treatment of pressure ulcers: 20-year experience.
Arch Phys Med Rehabil 2000;81:1556-62. Objective: To review the outcomes of surgical …

Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.

PW Nance, J Bugaresti, K Shellenberger, W Sheremata… - Neurology, 1994 - europepmc.org
Tizanidine, an imidazoline that acts as an agonist at alpha 2-adrenergic receptors, has been
shown to be effective in reducing spasticity caused by MS. This multicenter study (14 sites) …

BOLD MRI of the human cervical spinal cord at 3 tesla

PW Stroman, PW Nance… - Magnetic Resonance in …, 1999 - Wiley Online Library
The feasibility of functional MRI of the spinal cord was investigated by carrying out blood
oxygen‐level dependent (BOLD) imaging of the human cervical spinal cord at a field of 3 T. …

Intravenous pamidronate attenuates bone density loss after acute spinal cord injury

PW Nance, O Schryvers, W Leslie, S Ludwig… - Archives of physical …, 1999 - Elsevier
Objective: To compare the effects of a 6-month treatment with intravenous pamidronate (30-mg
infusion once per month) to conventional rehabilitation without pamidronate on bone …

Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury

EG Pearson, PW Nance, WD Leslie… - Archives of physical …, 1997 - Elsevier
Objective: To compare the effects of a 30-week trial of cyclical etidronate therapy (starting
within 6 weeks of spinal cord injury [SCI]) and conventional rehabilitation without etidronate …

Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis

PW Nance, WA Sheremata, SG Lynch… - Archives of …, 1997 - jamanetwork.com
Background: Spasticity is a serious problem in multiple sclerosis (MS) and many patients do
not achieve a satisfactory response to currently available oral antispasticity drugs. …

Efficacy and safety of Tol Terodine in people with neurogenic detrusor overactivity

KD Ethans, PW Nance, RJ Bard, AR Casey… - The journal of spinal …, 2004 - Taylor & Francis
Objective: To compare tolterodine with oxybutynin and placebo in people with neuragenie
detrusor overactivity. Design: Prospective, randomized, double-blind, crossover trial plus open…

Dissociated hip and spine demineralization: a specific finding in spinal cord injury

WD Leslie, PW Nance - Archives of physical medicine and …, 1993 - archives-pmr.org
Bone mineral density of the lumbar spine and right hip was measured with dual x-ray
absorptiometry in 14 men with chronic spinal cord injury (SCI). The pattern of demineralization was …

[HTML][HTML] International spinal cord injury musculoskeletal basic data set

…, A Curt, LA Harvey, M Jane Mulcahey, PW Nance… - Spinal Cord, 2012 - nature.com
Objectives: To develop an International Spinal Cord Injury (SCI) Musculoskeletal Basic Data
Set as part of the International SCI Data Sets to facilitate consistent collection and reporting …

A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients

PW Nance - The Journal of The American Paraplegia Society, 1994 - Taylor & Francis
In twenty-five SCI subjects, antispasticity effects of three putative antispasticity agents [clonidine
(an alpha-2 noradrenergic agonist), cyproheptadine (a 5-HT 2 antagonist) and baclofen (…